Home NDC 0409-2336-01 NDC 0409-2336-01 - Deferoxamine Mesylate This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0409-2336
Requested NDC 0409-2336-01
Package NDCs from labels 0409-2336-01, 0409-2336-10, 0409-2336-13
Manufacturer Hospira, Inc.
Effective date 2026-04-06
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0409-2336-01 Deferoxamine Mesylate 1 in 1 VIAL, SINGLE-USE INJECTION, POWDER, LYOPHILIZED, 1 27 0409-2336-10 Deferoxamine Mesylate 4 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 4 27
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0409-2336 DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] 23 Legacy NDC, 2 package rows 20240319_f9ab6b1c-98d0-4373-0e9b-b10cb4a67543.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded DEFEROXAMINE MESYLATE ACTIVE INGREDIENT V9TKO7EO6K DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] 11 DEFEROXAMINE MESYLATE ACTIVE INGREDIENT V9TKO7EO6K DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] 11 DEFEROXAMINE ACTIVE MOIETY J06Y7MXW4D DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] 11 DEFEROXAMINE ACTIVE MOIETY J06Y7MXW4D DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] 11
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 9 of 9 · 168 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.